E
Achieve Life Sciences, Inc.
ACHV
$2.42
-$0.13-5.10%
E
Sell
3/12/2025Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 3/12/2025 due to a decline in the total return index, valuation index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 3/12/2025 due to a decline in the total return index, valuation index and volatility index.
D
Sell
2/26/2025Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 2/26/2025 due to an increase in the volatility index and valuation index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 2/26/2025 due to an increase in the volatility index and valuation index.
E
Sell
2/11/2025Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 2/11/2025 due to a decline in the total return index, valuation index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 2/11/2025 due to a decline in the total return index, valuation index and volatility index.
D
Sell
1/24/2025Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 1/24/2025 due to an increase in the total return index, valuation index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 1/24/2025 due to an increase in the total return index, valuation index and volatility index.
E
Sell
9/26/2024Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 9/26/2024 due to a decline in the volatility index, valuation index and growth index. EBIT declined 40.94% from -$5.98M to -$8.43M.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 9/26/2024 due to a decline in the volatility index, valuation index and growth index. EBIT declined 40.94% from -$5.98M to -$8.43M.
D
Sell
4/11/2024Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 4/11/2024 due to an increase in the valuation index, growth index and volatility index. EBIT increased 33.26% from -$6.57M to -$4.39M, earnings per share increased from -$0.3364 to -$0.2587, and operating cash flow increased 15.03% from -$5.14M to -$4.36M.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 4/11/2024 due to an increase in the valuation index, growth index and volatility index. EBIT increased 33.26% from -$6.57M to -$4.39M, earnings per share increased from -$0.3364 to -$0.2587, and operating cash flow increased 15.03% from -$5.14M to -$4.36M.
E
Sell
9/7/2023Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 9/7/2023 due to a decline in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 9/7/2023 due to a decline in the volatility index and total return index.
D
Sell
8/17/2023Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 8/17/2023 due to an increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.82 to 7.37, and debt to equity declined from 37.09 to 1.63.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 8/17/2023 due to an increase in the solvency index, total return index and valuation index. The quick ratio increased from 0.82 to 7.37, and debt to equity declined from 37.09 to 1.63.
E
Sell
5/22/2023Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 5/22/2023 due to a decline in the growth index, valuation index and solvency index. Debt to equity increased from 1.94 to 37.09, and the quick ratio declined from 1.15 to 0.82.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 5/22/2023 due to a decline in the growth index, valuation index and solvency index. Debt to equity increased from 1.94 to 37.09, and the quick ratio declined from 1.15 to 0.82.
D
Sell
5/1/2023Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 5/1/2023 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.349 to -$0.8297, EBIT increased 14.06% from -$12.64M to -$10.86M, and operating cash flow increased 1.45% from -$11.31M to -$11.14M.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 5/1/2023 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$1.349 to -$0.8297, EBIT increased 14.06% from -$12.64M to -$10.86M, and operating cash flow increased 1.45% from -$11.31M to -$11.14M.
E
Sell
3/14/2023Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 03/14/2023.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 1.18 to 15.12, and the quick ratio declined from 5.54 to 2.65.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 2/8/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 1.18 to 15.12, and the quick ratio declined from 5.54 to 2.65.
D
Sell
8/15/2022Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 8/15/2022 due to a decline in the solvency index, valuation index and volatility index. Debt to equity increased from 0.71 to 1.18, and the quick ratio declined from 9.06 to 5.54.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 8/15/2022 due to a decline in the solvency index, valuation index and volatility index. Debt to equity increased from 0.71 to 1.18, and the quick ratio declined from 9.06 to 5.54.
D
Sell
8/4/2022Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 8/4/2022 due to an increase in the volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 8/4/2022 due to an increase in the volatility index.
D
Sell
7/18/2022Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 7/18/2022 due to a decline in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 7/18/2022 due to a decline in the volatility index and total return index.
D
Sell
5/23/2022Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 5/23/2022 due to an increase in the volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 5/23/2022 due to an increase in the volatility index.
D
Sell
5/13/2022Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 05/13/2022.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 05/13/2022.
D
Sell
4/21/2022Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index and volatility index. The quick ratio declined from 10.88 to 9.49.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index and volatility index. The quick ratio declined from 10.88 to 9.49.
D
Sell
11/3/2021Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 11/3/2021 due to an increase in the total return index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 11/3/2021 due to an increase in the total return index and volatility index.
D
Sell
10/13/2021Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 10/13/2021 due to a decline in the volatility index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 10/13/2021 due to a decline in the volatility index.
D
Sell
9/23/2021Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 9/23/2021 due to an increase in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 9/23/2021 due to an increase in the volatility index and total return index.
D
Sell
9/8/2021Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 9/8/2021 due to a decline in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 9/8/2021 due to a decline in the volatility index and total return index.
D
Sell
8/18/2021Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 8/18/2021 due to an increase in the volatility index, solvency index and growth index. The quick ratio increased from 8.43 to 8.99.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 8/18/2021 due to an increase in the volatility index, solvency index and growth index. The quick ratio increased from 8.43 to 8.99.
D
Sell
8/10/2021Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 8/10/2021 due to a decline in the growth index and valuation index. Operating cash flow declined 160.16% from -$2.48M to -$6.45M, EBIT declined 69.12% from -$4.72M to -$7.98M, and earnings per share declined from -$1.1072 to -$1.3045.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 8/10/2021 due to a decline in the growth index and valuation index. Operating cash flow declined 160.16% from -$2.48M to -$6.45M, EBIT declined 69.12% from -$4.72M to -$7.98M, and earnings per share declined from -$1.1072 to -$1.3045.
D
Sell
1/13/2021Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 1/13/2021 due to an increase in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 1/13/2021 due to an increase in the volatility index and total return index.
D
Sell
12/28/2020Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 12/28/2020 due to a decline in the volatility index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 12/28/2020 due to a decline in the volatility index.
D
Sell
12/8/2020Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 12/8/2020 due to an increase in the volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 12/8/2020 due to an increase in the volatility index.
D
Sell
11/19/2020Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 11/19/2020 due to a decline in the solvency index and growth index. Operating cash flow declined 97.22% from -$2.2M to -$4.34M, and EBIT declined 28.65% from -$2.92M to -$3.75M.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 11/19/2020 due to a decline in the solvency index and growth index. Operating cash flow declined 97.22% from -$2.2M to -$4.34M, and EBIT declined 28.65% from -$2.92M to -$3.75M.
D
Sell
9/17/2020Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 9/17/2020 due to an increase in the total return index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 9/17/2020 due to an increase in the total return index and volatility index.
D
Sell
9/2/2020Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 9/2/2020 due to a decline in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 9/2/2020 due to a decline in the volatility index and total return index.
D
Sell
8/7/2020Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 8/7/2020 due to an increase in the valuation index, growth index and volatility index. Operating cash flow increased 50.73% from -$4.46M to -$2.2M, earnings per share increased from -$2.1463 to -$1.68, and EBIT increased 13.08% from -$3.36M to -$2.92M.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 8/7/2020 due to an increase in the valuation index, growth index and volatility index. Operating cash flow increased 50.73% from -$4.46M to -$2.2M, earnings per share increased from -$2.1463 to -$1.68, and EBIT increased 13.08% from -$3.36M to -$2.92M.
D
Sell
8/5/2020Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 8/5/2020 due to a decline in the valuation index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 8/5/2020 due to a decline in the valuation index and volatility index.
D
Sell
7/21/2020Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 7/21/2020 due to an increase in the solvency index, volatility index and growth index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 7/21/2020 due to an increase in the solvency index, volatility index and growth index.
D
Sell
5/15/2020Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 5/15/2020 due to a decline in the solvency index, volatility index and growth index. Operating cash flow declined 30.67% from -$3.41M to -$4.46M, and EBIT declined 4.61% from -$3.21M to -$3.36M.
Achieve Life Sciences, Inc. (ACHV) was downgraded to D- from D on 5/15/2020 due to a decline in the solvency index, volatility index and growth index. Operating cash flow declined 30.67% from -$3.41M to -$4.46M, and EBIT declined 4.61% from -$3.21M to -$3.36M.
D
Sell
5/6/2020Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 5/6/2020 due to an increase in the volatility index and growth index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D from D- on 5/6/2020 due to an increase in the volatility index and growth index.
D
Sell
3/16/2020Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 3/16/2020 due to an increase in the solvency index and volatility index. The quick ratio increased from 2.35 to 5.81.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 3/16/2020 due to an increase in the solvency index and volatility index. The quick ratio increased from 2.35 to 5.81.
E
Sell
2/28/2020Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 2/28/2020 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 3.5 to 2.35, and EBIT declined 1.5% from -$3.66M to -$3.72M.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 2/28/2020 due to a decline in the growth index, volatility index and solvency index. The quick ratio declined from 3.5 to 2.35, and EBIT declined 1.5% from -$3.66M to -$3.72M.
D
Sell
8/13/2019Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 8/13/2019 due to a major increase in the growth index and solvency index. The quick ratio increased from 2.42 to 3.5, earnings per share increased from -$0.8784 to -$0.5041, and EBIT increased 38.35% from -$5.94M to -$3.66M.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 8/13/2019 due to a major increase in the growth index and solvency index. The quick ratio increased from 2.42 to 3.5, earnings per share increased from -$0.8784 to -$0.5041, and EBIT increased 38.35% from -$5.94M to -$3.66M.
E
Sell
8/6/2019Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 8/6/2019 due to a noticeable decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.5461 to -$0.8784, EBIT declined 60.15% from -$3.71M to -$5.94M, and the quick ratio declined from 4.47 to 2.42.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 8/6/2019 due to a noticeable decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.5461 to -$0.8784, EBIT declined 60.15% from -$3.71M to -$5.94M, and the quick ratio declined from 4.47 to 2.42.
D
Sell
2/25/2019Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 2/25/2019 due to an increase in the solvency index, efficiency index and volatility index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 2/25/2019 due to an increase in the solvency index, efficiency index and volatility index.
E
Sell
6/25/2018Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 6/25/2018 due to a decline in the volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 6/25/2018 due to a decline in the volatility index and total return index.
D
Sell
6/8/2018Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 6/8/2018 due to an increase in the valuation index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E+ on 6/8/2018 due to an increase in the valuation index.
E
Sell
5/24/2018Downgrade
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 5/24/2018 due to a decline in the valuation index, volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E+ from D- on 5/24/2018 due to a decline in the valuation index, volatility index and total return index.
D
Sell
5/1/2018Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E on 5/1/2018 due to an increase in the solvency index, volatility index and total return index.
Achieve Life Sciences, Inc. (ACHV) was upgraded to D- from E on 5/1/2018 due to an increase in the solvency index, volatility index and total return index.
E
Sell
2/1/2018Upgraded
Achieve Life Sciences, Inc. (ACHV) was upgraded to E from E- on 02/01/2018.
Achieve Life Sciences, Inc. (ACHV) was upgraded to E from E- on 02/01/2018.
E
Sell
11/13/2017None
Achieve Life Sciences, Inc. (ACHV) was downgraded to E- from U on 11/13/2017.
Achieve Life Sciences, Inc. (ACHV) was downgraded to E- from U on 11/13/2017.
NASDAQ
04/03/2025 4:00PM Eastern
Quotes delayed
